BRPI0513549A - composições farmacêuticas para o tratamento de leishmaniose - Google Patents
composições farmacêuticas para o tratamento de leishmanioseInfo
- Publication number
- BRPI0513549A BRPI0513549A BRPI0513549-4A BRPI0513549A BRPI0513549A BR PI0513549 A BRPI0513549 A BR PI0513549A BR PI0513549 A BRPI0513549 A BR PI0513549A BR PI0513549 A BRPI0513549 A BR PI0513549A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- leishmaniasis
- pharmaceutical compositions
- parasitic diseases
- precursors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
COMPOSIçõES FARMACêUTICAS PARA O TRATAMENTO DE LEISHMANIOSE. A presente invenção se refere ao uso de pelo menos um composto da seguinte fórmula geral (I): no qual R representa OH ou NH~ 2~, ou de precursores ou derivados deste, ou dos sais farmaceuticamente aceitáveis de referido composto ou de seus precursores ou derivados, para a manufatura de um medicamento pretendido para a prevenção ou tratamento de doenças parasíticas, em particular de doenças parasíticas de protozoário, mais particularmente de leishmaniose, e especialmente para a prevenção ou para o tratamento de doenças parasíticas que ocorrem em pacientes imunodepressivos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58880204P | 2004-07-19 | 2004-07-19 | |
PCT/EP2005/007715 WO2006008082A1 (en) | 2004-07-19 | 2005-07-15 | Pharmaceutical compositions for the treatment of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0513549A true BRPI0513549A (pt) | 2008-05-06 |
Family
ID=34979717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0513549-4A BRPI0513549A (pt) | 2004-07-19 | 2005-07-15 | composições farmacêuticas para o tratamento de leishmaniose |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080039430A1 (pt) |
EP (1) | EP1768669B1 (pt) |
AT (1) | ATE447953T1 (pt) |
BR (1) | BRPI0513549A (pt) |
DE (1) | DE602005017629D1 (pt) |
ES (1) | ES2333889T3 (pt) |
WO (1) | WO2006008082A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010054382A1 (en) * | 2008-11-10 | 2010-05-14 | Elixir Pharmaceuticals, Inc. | Compounds, compositions, and methods for treating malaria or leishmaniasis |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
US20120295942A1 (en) | 2010-02-01 | 2012-11-22 | Nicholas James Devereux | Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302459A (en) * | 1980-03-19 | 1981-11-24 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives |
US4399151A (en) * | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
GB2103485B (en) * | 1981-08-10 | 1986-04-03 | Wellcone Foundation Limited Th | Liposomes containing antimonyanti-leishmanaisis drugs |
GB8330969D0 (en) * | 1983-11-21 | 1983-12-29 | Wellcome Found | Promoting healing |
DK0802257T3 (da) * | 1996-04-19 | 2002-10-28 | Nestle Sa | Udødeliggjort cellelinie fra epitelceller i human colon |
CA2302687A1 (en) * | 1997-09-11 | 1999-03-18 | Oxigene, Inc. | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
US6207879B1 (en) * | 1999-05-14 | 2001-03-27 | Dekalb Genetics Corporation | Maize RS81 promoter and methods for use thereof |
WO2000078268A2 (en) * | 1999-06-20 | 2000-12-28 | Elnour Abdel Magid Osman | Potentiation of chloroquine |
-
2005
- 2005-07-15 WO PCT/EP2005/007715 patent/WO2006008082A1/en active Application Filing
- 2005-07-15 DE DE602005017629T patent/DE602005017629D1/de active Active
- 2005-07-15 AT AT05772459T patent/ATE447953T1/de not_active IP Right Cessation
- 2005-07-15 BR BRPI0513549-4A patent/BRPI0513549A/pt not_active IP Right Cessation
- 2005-07-15 ES ES05772459T patent/ES2333889T3/es active Active
- 2005-07-15 US US11/632,845 patent/US20080039430A1/en not_active Abandoned
- 2005-07-15 EP EP05772459A patent/EP1768669B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
US20080039430A1 (en) | 2008-02-14 |
EP1768669B1 (en) | 2009-11-11 |
ES2333889T3 (es) | 2010-03-02 |
WO2006008082A1 (en) | 2006-01-26 |
ATE447953T1 (de) | 2009-11-15 |
EP1768669A1 (en) | 2007-04-04 |
DE602005017629D1 (de) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
SE0202462D0 (sv) | Novel use | |
TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
MX2008013836A (es) | Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos. | |
GB0112348D0 (en) | Compounds | |
WO2006116733A3 (en) | Protein kinase inhibitors | |
EP2620145A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ | |
UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
SE0202429D0 (sv) | Novel Compounds | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
SE9901573D0 (sv) | New compounds | |
DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
BRPI0513549A (pt) | composições farmacêuticas para o tratamento de leishmaniose | |
WO2006051314A3 (en) | Guanidine derivatives as inhibitors of ddah | |
WO2006031719A3 (en) | 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof | |
HK1075894A1 (en) | Prucalopride-n-oxide | |
MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
BRPI0415546A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2315 DE 19-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |